{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:47:13Z","timestamp":1793170033868,"version":"4.5.0"},"reference-count":50,"publisher":"American Chemical Society (ACS)","issue":"5","funder":[{"name":"Ministry of Education, Saudi Arabia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2016,5,2]]},"DOI":"10.1021\/acs.molpharmaceut.6b00096","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T21:08:19Z","timestamp":1458076099000},"page":"1688-1698","source":"Crossref","is-referenced-by-count":14,"title":["Amorphous Formulation and <i>in Vitro<\/i> Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone"],"prefix":"10.1021","volume":"13","author":[{"given":"Abdulmalik","family":"Alqurshi","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Science, King\u2019s College London, Franklin-Wilkins Building, 150 Stamford Street, London, U.K., SE1\r9NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahrae","family":"Kumar","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, King\u2019s College London, Franklin-Wilkins Building, 150 Stamford Street, London, U.K., SE1\r9NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"McDonald","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King\u2019s College London (National Addiction Centre), Addictions Sciences Building, 4 Windsor Walk, Denmark Hill, London, U.K., SE5 8BB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Strang","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King\u2019s College London (National Addiction Centre), Addictions Sciences Building, 4 Windsor Walk, Denmark Hill, London, U.K., SE5 8BB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Buanz","sequence":"additional","affiliation":[{"name":"UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London, U.K., WC1N 1AX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shagufta","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Quintiles Ltd, Quintiles Drug Research Unit at Guy\u2019s Hospital, 6 Newcomen Street London, U.K., SE1 1YR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Allen","sequence":"additional","affiliation":[{"name":"Quintiles Ltd, Quintiles Drug Research Unit at Guy\u2019s Hospital, 6 Newcomen Street London, U.K., SE1 1YR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Cameron","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 NHS Foundation Trust Pharmacy\rManufacturing Unit, Guy\u2019s Hospital,  Great Maze Pond, London, U.K., SE1 9RT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Rickard","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 NHS Foundation Trust Pharmacy\rManufacturing Unit, Guy\u2019s Hospital,  Great Maze Pond, London, U.K., SE1 9RT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verity","family":"Sandhu","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 NHS Foundation Trust Pharmacy\rManufacturing Unit, Guy\u2019s Hospital,  Great Maze Pond, London, U.K., SE1 9RT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Holt","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 NHS Foundation Trust Pharmacy\rManufacturing Unit, Guy\u2019s Hospital,  Great Maze Pond, London, U.K., SE1 9RT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Stansfield","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 NHS Foundation Trust Pharmacy\rManufacturing Unit, Guy\u2019s Hospital,  Great Maze Pond, London, U.K., SE1 9RT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Taylor","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, King\u2019s College London, Franklin-Wilkins Building, 150 Stamford Street, London, U.K., SE1\r9NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Forbes","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, King\u2019s College London, Franklin-Wilkins Building, 150 Stamford Street, London, U.K., SE1\r9NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Royall","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, King\u2019s College London, Franklin-Wilkins Building, 150 Stamford Street, London, U.K., SE1\r9NH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2016,3,28]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03140.x"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-013-9803-1"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181816214"},{"key":"ref4\/cit4","unstructured":"MHRA. Proposal to Allow Wider Access to Naloxone for Use in Emergencies. 2013, 26 Jun 2015 [cited 2015]. Available fromhttps:\/\/www.gov.uk\/government\/consultations\/proposal-to-allow-wider-access-to-naloxone-for-use-in-emergencies."},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2014.968657"},{"key":"ref6\/cit6","unstructured":"AMA. AMA Adopts New Policies to Improve Health of Nation on First Day of Voting at Annual Meeting. 2015 [cited 2015 Jun 26]. Available fromhttp:\/\/www.ama-assn.org\/ama\/pub\/news\/news\/2015\/2015-06-08-new-policies-annual-meeting.page."},{"key":"ref7\/cit7","unstructured":"WHO. Community management of opioid overdose. 2014, [cited 2015 June 26]. Available fromhttp:\/\/www.who.int\/substance_abuse\/publications\/management_opioid_overdose\/en\/."},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/476161"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.3109\/10903127.2011.640763"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(87)90147-5"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.02.042"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2006.04.012"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2013.08.011"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2011.01793.x"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21436"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.05.043"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.5.5.531"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(90)90136-3"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2011.01.027"},{"issue":"2","key":"ref20\/cit20","author":"Pfister W. R.","year":"2005","journal-title":"Pharm. Technol."},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.2012.01473.x"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2009.01.027"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(98)00338-X"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-009-0021-1"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-011-0575-6"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21816"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2013.871551"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2012.05.026"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21552"},{"key":"ref30\/cit30","unstructured":"ICH. Good manufacturing practice guide for active pharmaceutical ingredients q7. 2000, [cited 2015 13\/07\/2015]; Step 4. Available from:http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q7\/Step4\/Q7_Guideline.pdf."},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1023\/B:PHAM.0000016234.73023.75"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2008.09.024"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2015.01.020"},{"issue":"4","key":"ref34\/cit34","first-page":"101","volume":"20","author":"Mackenzie A. P.","year":"1966","journal-title":"Bull. Parenter. Drug Assoc."},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20185"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.3109\/10837459809028642"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1021\/ie9019616"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1023\/B:PHAM.0000008040.14958.bc"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1093\/ejo\/21.3.249"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011976615750"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1021\/js980001d"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics3030440"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.42.5"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodqual.2010.03.005"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2005.09.021"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9969(96)00055-6"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1007\/s11094-015-1161-8"},{"key":"ref48\/cit48","unstructured":"PubChem. Naloxone HCl CID = 5464092. 2005, [cited 2015 12-12-2015]. Available from:https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Naloxone_hydrochloride#section=Top."},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(02)00114-0"},{"key":"ref50\/cit50","doi-asserted-by":"publisher","DOI":"10.1016\/S0099-5428(08)60588-2"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6b00096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T17:10:11Z","timestamp":1682269811000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.6b00096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,28]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5,2]]}},"alternative-id":["10.1021\/acs.molpharmaceut.6b00096"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00096","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,28]]}}}